Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

31.73
Delayed Data
As of 4:01pm ET
 +0.45 / +1.44%
Today’s Change
30.22
Today|||52-Week Range
56.46
-12.47%
Year-to-Date
Teva Confirms CFO Is Leaving
Apr 26 / TheStreet.com - Paid Partner Content
Will Fresenius' $4.75 Billion Deal for Highly Coveted Akorn Spark a Bidding War?
Apr 25 / TheStreet.com - Paid Partner Content
Meyer Handelman Co Buys Enbridge, Broadridge Financial Solutions, CDK Global, Sells S...
Apr 26 / GuruFocus News - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of April 14
Apr 22 / GuruFocus News - Paid Partner Content
Lesa Sroufe & Co Buys Banco Bilbao Vizcaya Argentaria SA, Teva Pharmaceutical Industr...
Apr 25 / GuruFocus News - Paid Partner Content
Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharm...
Apr 20 / GuruFocus News - Paid Partner Content
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Apr 25 / TheStreet.com - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content
Teva Pharmaceutical CFO Stepping Down
Apr 25 / TheStreet.com - Paid Partner Content
Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug
Apr 13 / Zacks.com - Paid Partner Content